These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10453727)

  • 41. Physicochemical characteristics of the terbium-adriamycin complex and its effects on the sinus node automaticity.
    Canada RG; Carpentier RG
    Biochim Biophys Acta; 1991 Jan; 1073(1):136-41. PubMed ID: 1991128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heat sensitization to cisplatin in two cell lines with different drug sensitivities.
    Eichholtz-Wirth H; Hietel B
    Int J Hyperthermia; 1990; 6(1):47-55. PubMed ID: 2299237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reinterpretation of fluorescence of terbium ion-DNA complexes.
    Balcarová Z; Brabec V
    Biophys Chem; 1989 Mar; 33(1):55-61. PubMed ID: 2720090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin.
    de Avelar Júnior JT; Lima-Batista E; Castro Junior CJ; Pimenta AMC; Dos Santos RG; Souza-Fagundes EM; De Lima ME
    Front Mol Biosci; 2022; 9():876833. PubMed ID: 35601827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic fluorescence enhancement of Tb with aromatic monocarboxylic acids and TOPO-Triton X-100: role of Triton X-100 in synergism.
    Panigrahi BS
    Spectrochim Acta A Mol Biomol Spectrosc; 2000 Jun; 56A(7):1337-44. PubMed ID: 10888439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanostructured Layered Terbium Hydroxide Containing NASIDs:
    Gu QY; Qiu X; Liu JJ; Fu M; Chao JP; Ju RJ; Li XT
    J Nanosci Nanotechnol; 2018 Aug; 18(8):5320-5326. PubMed ID: 29458583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of BCL2L12 leads to cisplatin resistance in MDA-MB-231 breast cancer cells.
    Hong Y; Yang J; Wu W; Wang W; Kong X; Wang Y; Yun X; Zong H; Wei Y; Zhang S; Gu J
    Biochim Biophys Acta; 2008 Nov; 1782(11):649-57. PubMed ID: 18930135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells.
    Tassone P; Tagliaferri P; Perricelli A; Blotta S; Quaresima B; Martelli ML; Goel A; Barbieri V; Costanzo F; Boland CR; Venuta S
    Br J Cancer; 2003 Apr; 88(8):1285-91. PubMed ID: 12698198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells.
    Sprouse AA; Herbert BS
    Anticancer Res; 2014 Oct; 34(10):5363-74. PubMed ID: 25275030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electron microscopy evidence of gadolinium toxicity being mediated through cytoplasmic membrane dysregulation.
    Arino T; Faulkner D; Bustillo KC; An DD; Jorgens D; Hébert S; McKinley C; Proctor M; Loguinov A; Vulpe C; Abergel RJ
    Metallomics; 2024 Oct; 16(10):. PubMed ID: 39313325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.
    Monroe JD; Millay MH; Patty BG; Smith ME
    J Clin Neurosci; 2018 Nov; 57():152-156. PubMed ID: 30243600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells.
    Al-Qatati A; Aliwaini S
    Oncol Lett; 2017 Dec; 14(6):7993-7999. PubMed ID: 29344241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma.
    Paltoo DN; Canada RG
    Cancer Biochem Biophys; 1998 Oct; 16(3):213-27. PubMed ID: 10072206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells.
    Canada RG; Andrews PA; Mack KM; Haider A
    Biochim Biophys Acta; 1995 May; 1267(1):25-30. PubMed ID: 7779865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence.
    Canada RG; Paltoo DN
    Biochim Biophys Acta; 1998 Nov; 1448(1):85-98. PubMed ID: 9824675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells.
    Fuller TL; Canada RG
    Cancer Chemother Pharmacol; 1999; 44(3):249-52. PubMed ID: 10453727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells.
    Mack KM; Canada RG; Andrews PA
    Cancer Chemother Pharmacol; 1997; 39(3):217-22. PubMed ID: 8996523
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.